Diabetes and Cardiovascular Disease

No abstract is available for this paper.

• Publication year

  2019

• Venue

  The Diabetes Textbook

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-030-11815-0_46
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of medical care in diabetes-2017. Diabetes Care 2017;40(Suppl. 1):S1-S135

  2017cited by this paper
• Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk

  2017cited by this paper
• Compliance with guideline‐directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines–Coronary Artery Disease (GWTG‐CAD) program

  2017cited by this paper
• A pan-coronary artery angiographic study of the association between diabetes mellitus and progression or regression of coronary atherosclerosis

  2017cited by this paper
• Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis.

  2017cited by this paper
• Impact of empagliflozin in patients with diabetes and heart failure.

  2017cited by this paper
• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2017cited by this paper
• Inorganic Nitrate in Angina Study: A Randomized Double‐Blind Placebo‐Controlled Trial

  2017cited by this paper
• Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.

  2017cited by this paper
• Early Invasive Strategy and In‐Hospital Survival Among Diabetics With Non‐ST‐Elevation Acute Coronary Syndromes: A Contemporary National Insight

  2017cited by this paper
• Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.

  2017cited by this paper
• 2016 European Guidelines on cardiovascular disease prevention in clinical practice.

  2016cited by this paper
• -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw

  2016cited by this paper
• Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study

  2016cited by this paper
• What Should Be the Target Blood Pressure in Elderly Patients With Diabetes?

  2016cited by this paper
• Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

  2016cited by this paper
• Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis

  2016cited by this paper
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

  2016cited by this paper
• Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.

  2016cited by this paper
• Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

  2015cited by this paper
• The similarities and differences among patients with abdominal aortic aneurysms referred to a tertiary hospital and found at necropsy

  2015cited by this paper
• Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.

  2015cited by this paper
• Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study

  2015cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2015cited by this paper
• Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies.

  2015cited by this paper
• Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.

  2015cited by this paper
• Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay

  2015cited by this paper
• Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis

  2015cited by this paper
• Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

  2015cited by this paper
• Association between Diabetes and Risk of Aortic Dissection: A Case-Control Study in a Chinese Population

  2015cited by this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Heart failure in the diabetic population – pathophysiology, diagnosis and management

  2014cited by this paper
• Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis

  2014cited by this paper
• Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.

  2014cited by this paper
• 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.

  2014cited by this paper
• Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

  2014cited by this paper
• Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction.

  2014cited by this paper
• Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies.

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Co‐morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

  2014cited by this paper
• Diabetes Mellitus and Aortic Aneurysm Rupture

  2014cited by this paper
• Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial

  2014cited by this paper
• 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca

  2014cited by this paper
• Biomarkers and acute coronary syndromes: an update.

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.

  2014cited by this paper
• Relation between the GRACE score and severity of atherosclerosis in acute coronary syndrome.

  2014cited by this paper
• Response to letter regarding article, "Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?".

  2014cited by this paper
• Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors

  2013cited by this paper
• Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction.

  2013cited by this paper
• Methods of accelerated atherosclerosis in diabetic patients

  2013cited by this paper
• Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).

  2013cited by this paper
• Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization: Insights Into the Safety of Long-Term Dual Antiplatelet Therapy With Reduced-Dose Prasugrel Versus Standard-Dose Clopidogrel

  2013cited by this paper
• Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.

  2013cited by this paper
• Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

  2013cited by this paper
• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

  2013cited by this paper
• Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials

  2013cited by this paper
• Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

  2013cited by this paper
• 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

  2013cited by this paper
• 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass

  2012cited by this paper
• Basal insulin and cardiovascular and other outcomes in dysglycemia.

  2012cited by this paper
• Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry

  2012cited by this paper
• 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physi

  2012cited by this paper
• Ventricular repolarization in diabetic patients: characterization and clinical implications.

  2012cited by this paper
• Impact of Diabetes Mellitus on Vessel Response in the Drug-Eluting Stent Era: Pooled Volumetric Intravascular Ultrasound Analyses

  2012cited by this paper
• A simple strategy for screening for glucose intolerance, using glycated haemoglobin, in individuals admitted with acute coronary syndrome

  2012cited by this paper
• How to use high-sensitivity cardiac troponins in acute cardiac care

  2012cited by this paper
• Diabetic cardiomyopathy: pathophysiology and clinical features

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain.

  2012cited by this paper
• EuroSCORE II.

  2012cited by this paper
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  2012cited by this paper
• The strange relationship between diabetes and abdominal aortic aneurysm.

  2012cited by this paper
• Strategies for multivessel revascularization in patients with diabetes.

  2012cited by this paper
• Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

  2011cited by this paper
• Death during intensive glycemic therapy of diabetes: mechanisms and implications.

  2011cited by this paper
• Effects of Optimal Medical Treatment With or Without Coronary Revascularization on Angina and Subsequent Revascularizations in Patients With Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease

  2011cited by this paper
• Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.

  2011cited by this paper
• Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

  2011cited by this paper
• Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.

  2011cited by this paper
• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  2011cited by this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cited by this paper
• Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

  2011cited by this paper
• Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.

  2011cited by this paper
• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

  2011cited by this paper
• A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease

  2011cited by this paper
• Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

  2011cited by this paper
• Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Me

  2011cited by this paper
• Gender differences in symptoms of myocardial ischaemia.

  2011cited by this paper
• AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

  2011cited by this paper
• Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization?

  2011cited by this paper
• Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.

  2011cited by this paper
• Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community

  2011cited by this paper
• Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

  2010cited by this paper
• The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence

  2010cited by this paper

• No citing papers are available for this paper.